Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua D Lee

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Addiction (Abingdon, England)|January 23, 2019
Commentary on Jones & McCance-Katze (2019): Buprenorphine and the glass half full-why can't we prescribe more of it, and will nurse practitioners and physician assistants fulfill a chronic unmet need?Joshua D Lee, Jennifer McNeely
Lancet (London, England)|February 23, 2019
Opioid addiction: long-acting formulations for a long-term disorderNikolaj Kunøe, Joshua D Lee
Journal of Addiction Medicine|July 25, 2012
Internet highs--seizures after consumption of synthetic cannabinoids purchased onlineBabak Tofighi, Joshua D Lee
The Lancet. HIV|March 19, 2019
Extended-release opioid antagonists and HIV treatmentJoshua D Lee, Nikolaj Kunoe
The Neurohospitalist|December 24, 2021
Natalizumab Rebound in Multiple SclerosisJoshua D Lee, Tychicus Chen
Substance Abuse|January 24, 2012
Opioid pharmacotherapy in criminal justice settings: now is the timeJoshua D Lee, Josiah D Rich
Journal of the American College of Cardiology|March 15, 2018
Cannabis and Heart Disease: Forward Into the Great Unknown?Joshua D Lee, Daniel Schatz, Judith Hochman
Journal of Addiction Medicine|September 26, 2014
Unobserved "home" induction onto buprenorphineJoshua D Lee, Frank Vocci, David A Fiellin
Journal of Substance Abuse Treatment|November 14, 2017
High prevalence of urine tampering in an office-based opioid treatment practice detected by evaluating the norbuprenorphine to buprenorphine ratioAnthony J Accurso, Joshua D Lee, Jennifer McNeely
The Neurohospitalist|January 18, 2024
Parakinesia Brachialis Oscitans and Excessive yawning From Tumefactive DemyelinationChia-Chen Tsai, Joshua D Lee, Tychicus Chen
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Addiction (Abingdon, England)|January 23, 2019
Commentary on Jones & McCance-Katze (2019): Buprenorphine and the glass half full-why can't we prescribe more of it, and will nurse practitioners and physician assistants fulfill a chronic unmet need?Joshua D Lee, Jennifer McNeely
Lancet (London, England)|February 23, 2019
Opioid addiction: long-acting formulations for a long-term disorderNikolaj Kunøe, Joshua D Lee
Journal of Addiction Medicine|July 25, 2012
Internet highs--seizures after consumption of synthetic cannabinoids purchased onlineBabak Tofighi, Joshua D Lee
The Lancet. HIV|March 19, 2019
Extended-release opioid antagonists and HIV treatmentJoshua D Lee, Nikolaj Kunoe
The Neurohospitalist|December 24, 2021
Natalizumab Rebound in Multiple SclerosisJoshua D Lee, Tychicus Chen
Substance Abuse|January 24, 2012
Opioid pharmacotherapy in criminal justice settings: now is the timeJoshua D Lee, Josiah D Rich
Journal of the American College of Cardiology|March 15, 2018
Cannabis and Heart Disease: Forward Into the Great Unknown?Joshua D Lee, Daniel Schatz, Judith Hochman
Journal of Addiction Medicine|September 26, 2014
Unobserved "home" induction onto buprenorphineJoshua D Lee, Frank Vocci, David A Fiellin
Journal of Substance Abuse Treatment|November 14, 2017
High prevalence of urine tampering in an office-based opioid treatment practice detected by evaluating the norbuprenorphine to buprenorphine ratioAnthony J Accurso, Joshua D Lee, Jennifer McNeely
The Neurohospitalist|January 18, 2024
Parakinesia Brachialis Oscitans and Excessive yawning From Tumefactive DemyelinationChia-Chen Tsai, Joshua D Lee, Tychicus Chen
Pageof 13